Weekly FDA Drug Pipeline Calendar (Feb 6 - Feb 10)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
BIGGEST MOVERS FROM THIS WEEK
$Hillstream BioPharma(HILS.US$ shares closed the week up 85% at $1.11 after it entered into a an exclusive license agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein. The deal allows Hillstream to develop anti-MUC1-C antibodies to selectively deliver HSB-1216 targeting CSC by the induction of ferroptosis.
$Biophytis(BPTS.US$ announced that its Phase 2/3 COVA trial of Sarconeos to treat COVID-19-related respiratory failure, met its primary endpoint. Shares closed the week up 45% at $0.68.
EVENTS TO WATCH
Tuesday, February 7, 2023
Dec. International trade deficit 8:30am ET
Dec. Consumer credit Report 3:00pm ET
Wednesday, February 8, 2023
Dec. Wholesale inventories (revision) 10:30am ET
Thursday, February 9, 2023
Feb 4. Initial jobless claims 8:30am ET
Jan 28. Continuing jobless claims 8:30am ET
Friday, February 10, 2023
Jan. Federal budget balance 2:00pm ET
Source: BioPharmCatalyst, Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
We are the content provider of Moomoo Courses.
909Followers
8Following
1458Visitors
Follow